GILEAD SCIENCES, INC

GILD
Real-time Estimate Quote. Real-time Estimate  - 11/24 04:03:15 pm
60.3USD +0.68%
Prev.59.8900
Open59.6300
High60.9800
Low59.5900
Volume8 693 719
Latest news
7h ago
21h ago
1d ago
1d ago
Chart GILEAD SCIENCES, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBearishBearish
Resistance61,166,369,4
Spread/Res.-1,2%-9,0%-13%
Spread/Supp.0,80%3,8%3,8%
Support59,958,258,2
Financials
Sales 2020 23 650 M - -
Net income 2020 34,3 M - -
Net Debt 2020 20 525 M - -
P/E ratio 2020 -4 394x
Yield 2020 4,55%
Capitalization 75 074 M 75 074 M -
EV / Sales 2020 4,04x
EV / Sales 2021 3,85x
Nbr of Employees 11 800
Free-Float 99,6%
Company
Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows:
- sale of drugs (98.5%): for the treatment of HIV, hepatitis B virus and hepatitis C virus (93.4% of net sales) and other (6.6%; primarily...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2020-12-05 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 30
Average target price 73,52 $
Last Close Price 59,89 $
Spread / Highest target 75,3%
Spread / Average Target 22,8%
Spread / Lowest Target -3,16%